Tech Company Inital Public Offerings

Agile Therapeutics IPO

Agile Therapeutics was purchased by . Shares became public on 5/23/2014.

Transaction Overview

Company Name
Announced On
5/23/2014
Transaction Type
IPO
Amount
$55,200,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
101 Poor Farm Rd.
Princeton, NJ 08540
USA
Email Address
Overview
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Profile
Agile Therapeutics LinkedIn Company Profile
Social Media
Agile Therapeutics Company Twitter Account
Company News
Agile Therapeutics News
Facebook
Agile Therapeutics on Facebook
YouTube
Agile Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alfred Altomari
  Alfred Altomari LinkedIn Profile  Alfred Altomari Twitter Account  Alfred Altomari News  Alfred Altomari on Facebook
Chief Financial Officer
Scott Coiante
  Scott Coiante LinkedIn Profile  Scott Coiante Twitter Account  Scott Coiante News  Scott Coiante on Facebook
VP - General Counsel
Geoffrey Gilmore
  Geoffrey Gilmore LinkedIn Profile  Geoffrey Gilmore Twitter Account  Geoffrey Gilmore News  Geoffrey Gilmore on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/23/2014: MphRx venture capital transaction
Next: 5/23/2014: Dejero venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary